Stem Cell Transplant Reviewed for Peripheral T - Cell Lymphoma
Three - and five - year overall survival similar with allogeneic or autologous HSCT, but transplant - related mortality higher with allogeneic HSCT
Source: The Doctors Lounge - Oncology - Category: Cancer & Oncology Tags: Oncology, Pathology, Journal, Source Type: news
More News: Cancer & Oncology | Lymphoma | Pathology | Stem Cell Therapy | Stem Cells | T-cell Lymphoma | Transplants